This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Anaxis Pharma Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: John Thomas Feutrill: Innovator in Sulphonamide Compounds
Introduction
John Thomas Feutrill is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of pharmaceuticals, particularly through his work on sulphonamide compounds. His innovative approach has led to advancements in treatments for various medical conditions.
Latest Patents
Feutrill holds 1 patent related to sulphonamide compounds. This invention pertains to compounds of formula (I) and includes their salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs, and/or prodrugs. The patent also discusses the application of these compounds in treating necroptosis and inhibiting MLKL.
Career Highlights
Feutrill is associated with Anaxis Pharma Pty Ltd, where he continues to develop and refine his innovative ideas. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Feutrill collaborates with talented professionals in his field, including Christopher Gardner and Carole Annie Schuster-Klein. These partnerships enhance the research and development process, leading to more effective solutions in medicine.
Conclusion
John Thomas Feutrill's contributions to the field of sulphonamide compounds exemplify the impact of innovation in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for future medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile